Cote Adrian, Negrut Roxana Loriana, Salem Hany Abdulateif, Feder Bogdan, Pop Mircea Gheorghe, Maghiar Adrian Marius
County Clinical Emergency Hospital Bihor, 410087 Oradea, Romania.
Department of Surgical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.
Diagnostics (Basel). 2025 Jan 15;15(2):192. doi: 10.3390/diagnostics15020192.
: Colon cancer is one of the main causes of cancer-related mortality worldwide. Among its histopathological subtypes, mucinous adenocarcinoma (MAC) is characterized by a more aggressive behavior than non-mucinous adenocarcinoma (non-MAC). This study aimed to compare the clinical outcomes and postoperative recovery between MAC and non-MAC cases in order to better understand the treatment implications and optimize therapeutic strategies. : A retrospective cohort study was conducted on patients diagnosed and treated at the Bihor County Emergency Hospital between January 2019 and December 2022. Data were collected from the medical records. Patients were divided into two groups, based on the histopathological results: mucinous adenocarcinoma and non-mucinous adenocarcinoma. Statistical analysis included descriptive statistics, -tests, Chi-square tests, and ANOVA where appropriate. : A total of 191 patients were enrolled in this study, grouped in 36 cases of MAC and 155 cases of non-MAC. No significant statistical differences were found regarding hematological parameters. However, MAC was associated with higher rates of local invasion and a predominant right-sided colonic location, necessitating more frequent right colectomies. The overall mortality rate was significantly higher for MAC, indicating its aggressive nature. : MAC presents higher local invasion rates and overall mortality. The aggressiveness of MAC underscores the need for tailored treatment approaches to optimize patient outcomes. Future large-scale studies are recommended to validate these findings and refine the therapeutic strategies.
结肠癌是全球癌症相关死亡的主要原因之一。在其组织病理学亚型中,黏液腺癌(MAC)的行为比非黏液腺癌(非MAC)更具侵袭性。本研究旨在比较MAC和非MAC病例的临床结局和术后恢复情况,以便更好地理解治疗意义并优化治疗策略。
对2019年1月至2022年12月期间在比霍尔县急诊医院诊断和治疗的患者进行了一项回顾性队列研究。数据从病历中收集。根据组织病理学结果将患者分为两组:黏液腺癌和非黏液腺癌。统计分析包括描述性统计、t检验、卡方检验以及在适当情况下的方差分析。
本研究共纳入191例患者,分为36例MAC和155例非MAC。血液学参数方面未发现显著统计学差异。然而,MAC与更高的局部侵袭率和主要位于右侧结肠的位置相关,因此需要更频繁地进行右半结肠切除术。MAC的总体死亡率显著更高,表明其侵袭性。
MAC表现出更高的局部侵袭率和总体死亡率。MAC的侵袭性突出了需要采用量身定制的治疗方法来优化患者结局。建议未来进行大规模研究以验证这些发现并完善治疗策略。